Opportunity Information: Apply for CDC RFA GH15 1510
Apply for CDC RFA GH15 1510
- The Centers for Disease Control and Prevention in the health sector is offering a public funding opportunity titled "Building Capacity along the Continuum from Prevention to Care and Treatment for Key Populations in the Central America Region under the Presidents Emergency Plan for AIDS Relief (PEPFAR)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.067 Global AIDS.
- This funding opportunity was created on Aug 22, 2014 and posted on Aug 20, 2014.
- Applicants must submit their applications by Oct 4, 2014. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Each selected applicant is eligible to receive up to $3,000,000.00 in funding.
- The number of recipients for this funding is limited to 2 candidate(s).
- Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).
- Eligible applicants that can apply for this FOA are listed below Government Organizations National Ministries of Health State and local governments or their Bona Fide Agents (this includes the District of Columbia, the Commonwealth of Puerto Rico, the Virgin Islands, the Commonwealth of the Northern Marianna Islands, American Samoa, Guam, the Federated States of Micronesia, the Republic of the Marshall Islands, and the Republic of Palau) . American Indian/Alaska Native tribal governments (federally recognized or state recognized) Political subdivisions of States (in consultation with States) Non government Organizations American Indian/Alaska native tribally designated organizations Alaska Native health corporations Tribal epidemiology centers Urban Indian health organizations Nonprofit with 501C3 IRS status (other than institution of higher education) Nonprofit without 501C3 IRS status (other than institution of higher education) Research institutions (that will perform activities deemed as non research) Colleges and Universities Community based organizations Faith based organizations For profit organizations (other than small business) Hospitals Small, minority, and women owned businesses All Other eligible organizations PEPFAR Local Partner definition To be considered eligible as a local partner under this Funding Opportunity Announcement, the applicant must submit supporting documentation demonstrating how their organization meets one of the three criteria listed below under the PEPFAR Local Partner definition. The supporting documentation must be included in the Appendices of the application and must be labeled as Eligibility Documentation for PEPFAR Local Partner Definition. Applicants that do not provide and/or label the supporting documentation required to meet the PEPFAR Local Partner definition above will not be considered eligible for review.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The Centers for Disease Control and Prevention (CDC) funding opportunity CDC-RFA-GH15-1510, titled "Building Capacity along the Continuum from Prevention to Care and Treatment for Key Populations in the Central America Region under PEPFAR," is a discretionary cooperative agreement designed to strengthen how Central American countries prevent, detect, and manage HIV among populations most affected by the epidemic. While overall adult HIV prevalence in the region is relatively low, the epidemic is concentrated in specific key populations, particularly men who have sex with men (MSM), transgender women, sex workers, and some ethnic groups such as the Garifuna. The core purpose of the award is to help Ministries of Health take stronger ownership of HIV programs by improving leadership, coordination, management, and implementation capacity, while maintaining quality and coverage. The opportunity is aligned with broader PEPFAR policy directions around sustainability and country ownership, including Institute of Medicine recommendations, the Central America Partnership Framework, and OGAC guidance for PEPFAR III.
The program is structured around two geographic clusters, and applicants can apply for one or both clusters but must submit a separate application and budget for each cluster they intend to implement. Cluster A includes Guatemala, Nicaragua, and Costa Rica. Cluster B includes Belize, El Salvador, Honduras, and Panama. CDC anticipated making two awards total, with an award ceiling of up to $3,000,000; there is no cost sharing or matching requirement listed. Because this is a cooperative agreement, the CDC is expected to have substantial involvement in program direction and oversight rather than acting only as a funder.
Across both clusters, one of the central technical priorities is expanding and improving VICITS (a Spanish acronym for the STI Sentinel Surveillance and Control Strategy). VICITS is positioned as a combination prevention approach that ties together stronger diagnosis and treatment of sexually transmitted infections, condom promotion and distribution, HIV counseling and testing, effective linkage to care, and an upgraded "second generation" surveillance information system. In practical terms, this emphasis reflects a push to integrate clinical services and prevention with higher-quality data systems, so countries can more accurately track STI/HIV trends among key populations, target resources, and improve service delivery where transmission risk is highest.
A second major priority in both clusters is rolling out and strengthening the Positive Health, Dignity, and Prevention (PHDP) strategy for people living with HIV (PLHIV). PHDP is framed as a comprehensive package that goes beyond clinical treatment to include sexual risk reduction counseling, condom provision, alcohol reduction counseling, support for disclosure, partner and family HIV counseling and testing, adherence support, STI screening and treatment, and family planning and safer pregnancy counseling. The overall intent is to reduce onward transmission risk while improving health outcomes and quality of life for PLHIV, using consistent counseling and prevention supports embedded within care and treatment services.
The opportunity also highlights concern about HIV drug resistance (DR) and supports monitoring activities consistent with World Health Organization guidance. In Cluster A, Costa Rica has an identified Year 1 focus on monitoring transmitted and acquired drug resistance among people initiating antiretroviral therapy (ART) and those failing ART. In Cluster B, Honduras has a similar Year 1 focus on drug resistance monitoring among people starting ART and those failing ART. This reflects a regional priority to detect and manage emerging resistance early, since drug resistance can undermine treatment success and increase the risk of transmission of resistant virus strains if not tracked and addressed through timely regimen changes and strong adherence support.
Cluster B includes additional country-specific activities centered in Honduras. These include multi-year technical assistance in monitoring and evaluation to strengthen the National AIDS Program M&E unit's ability to collect and analyze priority performance indicators from all 20 health regions (identified as Years 1 through 4). Cluster B also calls for adapting and implementing multilevel interventions intended to increase first-time HIV testing among MSM, referencing approaches such as Mpowerment, community-based HIV counseling and testing, and provider-initiated testing (PIT). Taken together, these Honduras-focused elements signal that, beyond service delivery improvements, CDC is seeking stronger national data use and targeted testing strategies to find undiagnosed infections earlier and connect people to prevention and treatment services more consistently.
Eligibility is broad and includes a wide range of government and non-government entities. Eligible applicants include national Ministries of Health; state, local, territorial, and tribal governments and their bona fide agents; nonprofits with or without 501(c)(3) status; research institutions conducting non-research program activities; colleges and universities; community-based and faith-based organizations; hospitals; and for-profit organizations (other than small businesses), including small, minority-, and women-owned businesses. The announcement also references a PEPFAR Local Partner definition requirement: organizations seeking to be considered local partners must provide specific supporting documentation in the application appendices, labeled as required, or they will be deemed ineligible for review. This reflects PEPFAR's emphasis on local ownership and leadership, making documentation of local partner status a gatekeeping step in the application process.
Key administrative details in the posted record include an original posting date of August 20, 2014, with closing dates listed as September 26, 2014 (original) and October 4, 2014 (current at the time), and an archive date of October 26, 2014. The CFDA number is 93.067 (Global AIDS). For applicants needing help accessing the full announcement, the contact point listed is CDC's Procurement and Grants Office Technical Information Management Section.
FAQs: CDC-RFA-GH15-1510 (CDC/PEPFAR Central America HIV Key Populations)
1) What is the funding opportunity CDC-RFA-GH15-1510?
CDC-RFA-GH15-1510 is a CDC discretionary cooperative agreement titled "Building Capacity along the Continuum from Prevention to Care and Treatment for Key Populations in the Central America Region under PEPFAR." It focuses on strengthening how Central American countries prevent, detect, and manage HIV among populations most affected by the epidemic.
2) What is the main goal of this cooperative agreement?
The core purpose is to help Ministries of Health take stronger ownership of HIV programs by improving leadership, coordination, management, and implementation capacity, while maintaining quality and coverage across the HIV prevention-to-care-and-treatment continuum.
3) Why does the opportunity emphasize "key populations"?
Although overall adult HIV prevalence in the region is described as relatively low, the epidemic is concentrated in certain key populations, especially men who have sex with men (MSM), transgender women, sex workers, and some ethnic groups such as the Garifuna. The program is designed to improve outcomes where transmission risk and burden are highest.
4) How is the program geographically organized?
The program is structured around two geographic clusters:
- Cluster A: Guatemala, Nicaragua, and Costa Rica
- Cluster B: Belize, El Salvador, Honduras, and Panama
5) Can an applicant apply for both clusters?
Yes. Applicants may apply for one or both clusters, but they must submit a separate application and a separate budget for each cluster they intend to implement.
6) How many awards did CDC anticipate making?
CDC anticipated making a total of two awards.
7) What is the maximum funding level for an award?
The award ceiling listed is up to $3,000,000.
8) Is cost sharing or matching required?
No cost sharing or matching requirement is listed for this opportunity.
9) What does it mean that this is a "cooperative agreement"?
As a cooperative agreement, CDC is expected to have substantial involvement in program direction and oversight, rather than serving only as a pass-through funder.
10) What are the main technical priorities across both clusters?
Two central technical priorities across both clusters are:
- Expanding and improving VICITS (STI Sentinel Surveillance and Control Strategy)
- Rolling out and strengthening the Positive Health, Dignity, and Prevention (PHDP) strategy for people living with HIV (PLHIV)
11) What is VICITS and what does it include?
VICITS (a Spanish acronym for the STI Sentinel Surveillance and Control Strategy) is positioned as a combination prevention approach that links:
- Improved diagnosis and treatment of sexually transmitted infections (STIs)
- Condom promotion and distribution
- HIV counseling and testing
- Effective linkage to care
- An upgraded "second generation" surveillance information system
The emphasis reflects integrating clinical services and prevention with higher-quality data systems to better track STI/HIV trends among key populations, target resources, and improve service delivery.
12) What is PHDP and what activities are included?
PHDP (Positive Health, Dignity, and Prevention) is described as a comprehensive package for people living with HIV that goes beyond clinical treatment. It includes:
- Sexual risk reduction counseling
- Condom provision
- Alcohol reduction counseling
- Support for disclosure
- Partner and family HIV counseling and testing
- Adherence support
- STI screening and treatment
- Family planning and safer pregnancy counseling
The intent is to reduce onward transmission risk while improving health outcomes and quality of life for PLHIV by embedding consistent counseling and prevention supports within care and treatment services.
13) Does the opportunity address HIV drug resistance?
Yes. The announcement highlights concerns about HIV drug resistance and supports monitoring activities consistent with World Health Organization guidance.
14) Which countries have a Year 1 focus on drug resistance monitoring?
The opportunity identifies Year 1 drug resistance monitoring focus in:
- Cluster A (Costa Rica): Monitoring transmitted and acquired drug resistance among people initiating antiretroviral therapy (ART) and those failing ART
- Cluster B (Honduras): Monitoring drug resistance among people starting ART and those failing ART
15) What is the rationale for drug resistance monitoring in this program?
The opportunity frames drug resistance monitoring as a regional priority to detect and manage emerging resistance early, because drug resistance can undermine treatment success and increase the risk of transmission of resistant virus strains if not tracked and addressed through timely regimen changes and strong adherence support.
16) Are there additional country-specific priorities within Cluster B?
Yes. Cluster B includes additional country-specific activities centered in Honduras, including multi-year technical assistance for monitoring and evaluation and targeted interventions to increase first-time HIV testing among MSM.
17) What monitoring and evaluation (M&E) support is described for Honduras?
Cluster B calls for Years 1 through 4 technical assistance in monitoring and evaluation to strengthen the National AIDS Program M&E unit's ability to collect and analyze priority performance indicators from all 20 health regions.
18) What strategies are referenced to increase first-time HIV testing among MSM in Honduras?
The opportunity calls for adapting and implementing multilevel interventions intended to increase first-time HIV testing among MSM, referencing approaches such as:
- Mpowerment
- Community-based HIV counseling and testing
- Provider-initiated testing (PIT)
19) Who is eligible to apply?
Eligibility is broad and includes many government and non-government entities, including:
- National Ministries of Health
- State, local, territorial, and tribal governments and their bona fide agents
- Nonprofits with or without 501(c)(3) status
- Research institutions conducting non-research program activities
- Colleges and universities
- Community-based and faith-based organizations
- Hospitals
- For-profit organizations (other than small businesses), including small, minority-, and women-owned businesses
20) What is the PEPFAR Local Partner documentation requirement mentioned?
The announcement notes that organizations seeking to be considered PEPFAR local partners must include specific supporting documentation in the application appendices, labeled as required. If the required documentation is not provided, the organization will be deemed ineligible for review.
21) What broader policy directions does this opportunity align with?
The opportunity is aligned with PEPFAR policy directions around sustainability and country ownership, including Institute of Medicine recommendations, the Central America Partnership Framework, and OGAC guidance for PEPFAR III.
22) What is the CFDA number for this opportunity?
The CFDA number listed is 93.067 (Global AIDS).
23) What were the key dates listed in the posted record?
The record lists an original posting date of August 20, 2014. The closing dates shown are September 26, 2014 (original) and October 4, 2014 (current at the time). The archive date is October 26, 2014.
24) Who is the contact for help accessing the full announcement?
The contact point listed for assistance accessing the full announcement is CDC's Procurement and Grants Office Technical Information Management Section.
Browse more opportunities from the same category: Health
Next opportunity: Small Business Innovation Research (SBIR) Technology Commercialization Assistance Program (TCAP)
Previous opportunity: National Park Service Archaeological Analysis, Documentation, and Development of Pilot Conservation Treatments for the Great House, Casa Grande Ruins National Monument
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for CDC RFA GH15 1510
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (CDC RFA GH15 1510) also looked into and applied for these:
| Funding Opportunity |
|---|
| Accelerating Comprehensive HIV/AIDS Service Delivery through Health Systems Capacity Building and Technical Assistance to District Health Teams and Health Facilities in Western and West Nile Regions in the Republic of Uganda under the Presidents Emer Apply for CDC RFA GH15 1591 Funding Number: CDC RFA GH15 1591 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $10,000,000 |
| Centers Without Walls for Collaborative Research in the Epilepsies Developing Disease Modifying or Prevention Therapies (U54) Apply for RFA NS 15 001 Funding Number: RFA NS 15 001 Agency: National Institutes of Health Category: Health Funding Amount: $3,000,000 |
| Increasing Access to HIV Prevention, Care and Treatment Services for Key Populations in Mozambique under the Presidents Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH15 1564 Funding Number: CDC RFA GH15 1564 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $4,500,000 |
| National Forum for State and Territorial Chief Executives (National Forum) Apply for HRSA 15 040 Funding Number: HRSA 15 040 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Voluntary Medical Male Circumcision as part of the National Program and the Combination Prevention Project in Botswana under the Presidents Emergency Plan for AIDS Relief Apply for CDC RFA GH15 1506 Funding Number: CDC RFA GH15 1506 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $4,000,000 |
| National Indian Health Outreach and Education Apply for HHS 2014 IHS NIHOE 0001 Funding Number: HHS 2014 IHS NIHOE 0001 Agency: Indian Health Service Category: Health Funding Amount: $766,000 |
| National Indian Health Outreach and Education III Apply for HHS 2014 IHS NIHOE 0003 Funding Number: HHS 2014 IHS NIHOE 0003 Agency: Indian Health Service Category: Health Funding Amount: $600,000 |
| Interdisciplinary Research to Understand the Vascular Contributions to Alzheimers Disease (R01) Apply for RFA AG 15 010 Funding Number: RFA AG 15 010 Agency: National Institutes of Health Category: Health Funding Amount: $750,000 |
| Comprehensive Approaches to Strengthening the Health System and HIV Response in the Republic of Mozambique under the Presidents Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH15 1556 Funding Number: CDC RFA GH15 1556 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $22,000,000 |
| Strengthening Mozambican Capacity in Health Information Systems in the Republic of Mozambique under the Presidents Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH15 1565 Funding Number: CDC RFA GH15 1565 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $2,500,000 |
| Public Private Partnerships in PEPFAR Countries under the Presidents Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH15 1539 Funding Number: CDC RFA GH15 1539 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $20,000,000 |
| Improving HIV/STI/TB Prevention, Treatment and Care Services for Mobile Populations in the Dominican Republic under the Presidents Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH15 1517 Funding Number: CDC RFA GH15 1517 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $300,000 |
| Capacity Building through Training and Mentoring for Treatment, Care and Support, Including PMTCT, TB/HIV, Laboratory, Informatics, and Cervical Cancer in Botswana under the Presidents Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH15 1504 Funding Number: CDC RFA GH15 1504 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $10,787,357 |
| Strengthening Local Capacity to Deliver Sustainable Quality Assured Universal Coverage of Clinical HIV/TB Services in Manzini Region, and Provide Central Level Technical Assistance to the National Tuberculosis Apply for CDC RFA GH15 1583 Funding Number: CDC RFA GH15 1583 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $4,200,000 |
| Strengthening Local Capacity to Deliver Sustainable Quality Assured Universal Coverage of Clinical HIV/TB Services in Lubombo Region, Apply for CDC RFA GH15 1582 Funding Number: CDC RFA GH15 1582 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $4,200,000 |
| Strengthening HIV/TB Laboratory Quality Management Systems and Services in the Kingdom of Swaziland under the Presidents Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH15 1581 Funding Number: CDC RFA GH15 1581 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $2,100,000 |
| Implementing an Electronic Monitoring and Reporting System in the Republic of Rwanda under the Presidents Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH15 1569 Funding Number: CDC RFA GH15 1569 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $310,000 |
| Monitoring and Evaluation Technical Support (METS) to Strengthen Monitoring and Evaluation, Disease Surveillance and the Capabilities of District Health Teams in the Republic of Uganda under the Presidents Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH15 1611 Funding Number: CDC RFA GH15 1611 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $5,400,000 |
| Strengthening Regional and Community Health Systems through Support for Field Epidemiology in Tanzania under the Presidens Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH15 1585 Funding Number: CDC RFA GH15 1585 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $450,000 |
| Technical Assistance for Strengthening National Laboratory Systems in Uganda under the Presidents Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH15 1593 Funding Number: CDC RFA GH15 1593 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $5,000,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "CDC RFA GH15 1510", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.